A Polymorphism in the Histone Deacetylase 1 Gene is Associated with the Response to Corticosteroids in Asthmatics

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2013 Dec 6

PMID 24307847

Citations 10

Authors

Min-Hye Kim

Sae-Hoon Kim

Yook-Keun Kim

Soo-Jong Hong

Kyung-Up Min

Sang-Heon Cho

Heung-Woo Park

Affiliations

Soon will be listed here.

Abstract

Background/aims: Recent investigations suggest that histone deacetylase 1 (HDAC1) and HDAC2 may be target molecules to predict therapeutic responses to corticosteroids. We evaluated the effects of variation in HDAC1 and HDAC2 on the response to corticosteroids in asthmatics.

Methods: Two single nucleotide polymorphisms (SNPs) were selected after resequencing HDAC1 and HDAC2. For the first analysis, we evaluated the association between those SNPs and asthma severity in 477 asthmatics. For the second analysis, we evaluated the effects of these SNPs on lung function improvements in response to corticosteroid treatment in 35 independent adult asthmatics and 70 childhood asthmatics.

Results: We found that one SNP in HDAC1 (rs1741981) was significantly related to asthma severity in a recessive model (corrected p = 0.036). Adult asthmatics who were homozygous for the minor allele of rs1741981 showed significantly lower % forced expiratory volume in 1 second (%FEV1) increases in response to systemic corticosteroids treatment compared with the heterozygotes or those homozygous for the major allele (12.7% ± 7.2% vs. 37.4% ± 33.7%, p = 0.018). Similarly, childhood asthmatics who were homozygous for the minor allele of rs1741981 showed significantly lower %FEV1 increases in response to inhaled corticosteroid treatment compared with the heterozygotes or those homozygous for the major allele (14.1% ± 5.9% vs. 19.4% ± 8.9%, p = 0.035).

Conclusions: The present study demonstrated that rs1741981 in HDAC1 was significantly associated with the response to corticosteroid treatment in asthmatics.

Citing Articles

The emerging role of histone deacetylase 1 in allergic diseases.

Wang Y, Wang H Front Immunol. 2022; 13:1027403.

PMID: 36311721 PMC: 9597694. DOI: 10.3389/fimmu.2022.1027403.

Epigenetic regulation of immune function in asthma.

Sharma S, Yang I, Schwartz D J Allergy Clin Immunol. 2022; 150(2):259-265.

PMID: 35717251 PMC: 9378596. DOI: 10.1016/j.jaci.2022.06.002.

RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model.

Peng X, Huang M, Zhao W, Lan Z, Wang X, Yuan Y BMC Pulm Med. 2022; 22(1):61.

PMID: 35148729 PMC: 8832863. DOI: 10.1186/s12890-022-01832-3.

Targeting HDAC Complexes in Asthma and COPD.

Zwinderman M, de Weerd S, Dekker F Epigenomes. 2021; 3(3).

PMID: 34968229 PMC: 8594684. DOI: 10.3390/epigenomes3030019.

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy.

Cazzola M, Rogliani P, Calzetta L, Matera M Pharmgenomics Pers Med. 2020; 13:261-271.

PMID: 32801837 PMC: 7414974. DOI: 10.2147/PGPM.S231471.

References

Ito K, Caramori G, Lim S, Oates T, Chung K, Barnes P . Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med. 2002; 166(3):392-6. DOI: 10.1164/rccm.2110060. View

Inglis G, Ingram M, Holloway C, Swan L, Birnie D, Hillis W . Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab. 1999; 84(11):4132-7. DOI: 10.1210/jcem.84.11.6146. View

Choi J, Oh S, Kang M, Kwon H, Oh G, Kim D . Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy. 2005; 35(1):89-96. DOI: 10.1111/j.1365-2222.2004.02006.x. View

Barnes P, Adcock I . Glucocorticoid resistance in inflammatory diseases. Lancet. 2009; 373(9678):1905-17. DOI: 10.1016/S0140-6736(09)60326-3. View

Lee P, Shatkay H . F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 2007; 36(Database issue):D820-4. PMC: 2238878. DOI: 10.1093/nar/gkm904. View

Ober C, Abney M, McPeek M . The genetic dissection of complex traits in a founder population. Am J Hum Genet. 2001; 69(5):1068-79. PMC: 1274354. DOI: 10.1086/324025. View

Haczku A, Alexander A, Brown P, Assoufi B, Li B, Kay A . The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol. 1994; 93(2):510-9. DOI: 10.1016/0091-6749(94)90361-1. View

Park H, Shin E, Lee J, Kim S, Kim S, Chang Y . Association between genetic variations in prostaglandin E2 receptor subtype EP3 gene (Ptger3) and asthma in the Korean population. Clin Exp Allergy. 2007; 37(11):1609-15. DOI: 10.1111/j.1365-2222.2007.02820.x. View

Schwartz J, Reuling F, Feinleib M, Garrison R, Collie D . Twin heritability study of the effect of corticosteroids on intraocular pressure. J Med Genet. 1972; 9(2):137-43. PMC: 1469045. DOI: 10.1136/jmg.9.2.137. View

10.

Barnes P . How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 2006; 148(3):245-54. PMC: 1751559. DOI: 10.1038/sj.bjp.0706736. View

11.

Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes P . Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 2005; 203(1):7-13. PMC: 2118081. DOI: 10.1084/jem.20050466. View

12.

Lee P, Shatkay H . An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics. 2009; 25(8):1048-55. DOI: 10.1093/bioinformatics/btp103. View

13.

Bhavsar P, Ahmad T, Adcock I . The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol. 2008; 121(3):580-4. DOI: 10.1016/j.jaci.2007.12.1156. View

14.

Barnes P . Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013; 131(3):636-45. DOI: 10.1016/j.jaci.2012.12.1564. View

15.

Corrigan C, Brown P, Barnes N, Szefler S, Tsai J, Frew A . Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 1991; 144(5):1016-25. DOI: 10.1164/ajrccm/144.5.1016. View

16.

Sandelin A, Wasserman W, Lenhard B . ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004; 32(Web Server issue):W249-52. PMC: 441510. DOI: 10.1093/nar/gkh372. View

17.

Barnes P, Ito K, Adcock I . Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet. 2004; 363(9410):731-3. DOI: 10.1016/S0140-6736(04)15650-X. View

18.

Grausenburger R, Bilic I, Boucheron N, Zupkovitz G, El-Housseiny L, Tschismarov R . Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J Immunol. 2010; 185(6):3489-97. PMC: 3175530. DOI: 10.4049/jimmunol.0903610. View

19.

Drazen J, Silverman E, Lee T . Heterogeneity of therapeutic responses in asthma. Br Med Bull. 2001; 56(4):1054-70. DOI: 10.1258/0007142001903535. View

20.

Bahadori K, Doyle-Waters M, Marra C, Lynd L, Alasaly K, Swiston J . Economic burden of asthma: a systematic review. BMC Pulm Med. 2009; 9:24. PMC: 2698859. DOI: 10.1186/1471-2466-9-24. View